Skip to main content
Benjamin Shneider, MD, Pediatric Gastroenterology, Houston, TX, Texas Children's Hospital

BenjaminShneiderMD

Pediatric Gastroenterology Houston, TX

Pediatric Hepatology and Liver Transplantation

Professor, Pediatrics, Baylor College of Medicine Chief of Section, Pediatric Gastroenterology, Hepatology and Nutrition

Dr. Shneider is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Shneider's full profile

Already have an account?

  • Office

    6701 Fannin St.
    Pediatric Gastroenterology, Hepatology and Nutrition
    Houston, TX 77030
    Phone+1 832-822-3608
  • Is this information wrong?

Education & Training

  • Children's Hospital/Boston Medical Center
    Children's Hospital/Boston Medical CenterResidency, Pediatrics, 1986 - 1989
  • University of Chicago Division of the Biological Sciences The Pritzker School of Medicine
    University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1986
  • Stanford University
    Stanford UniversityB.S, Chemistry, 1982

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2014 - 2026
  • PA State Medical License
    PA State Medical License 2007 - 2014
  • NY State Medical License
    NY State Medical License 1997 - 2013
  • CT State Medical License
    CT State Medical License 1989 - 1997
  • American Board of Pediatrics Pediatric Gastroenterology
  • American Board of Pediatrics Pediatric Transplant Hepatology

Awards, Honors, & Recognition

  • Best Doctors in America 2007
  • Elected Member The American Society for Clinical Investigation, 2005
  • America's Top Pediatricians: Pediatric Gastroenterology 2004, 2008
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Accuracy of the Pediatric End-Stage Liver Disease Score in Estimating Pretransplant Mortality Among Pediatric Liver Transplant Candidates  
    Robert H Squires, Benjamin L Shneider, JAMA
  • Bile acid pool dynamics in progressive familial intrahepatic cholestasis with partial external biliary diversion  
    J. Pediatr. Gastroenterol. Nutr, 1/1/2015
  • Byler's Disease-Early natural history, A single center case series  
    J. Pediatr. Gastroenterol. Nutr, 1/1/2015
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Lectures

  • Translational Investigations of Byler's Disease 
    Houston, TX - 1/16/2015
  • Stratifying Risk and Individualizing Care for Portal Hypertenson- Controversies and Challenges in Pediatrics 
    Baveno, Italy - 1/11/2015
  • Controversies in the Management of Varices in Children 
    Baveno, Italy - 1/11/2015
  • Join now to see all

Other

  • ATP8B1 Deficiency. 
    GeneReviews
    University of Washington, Seattle, WA - 1/1/2009
  • Low-gGT Familial Interhepatic Cholestasis 
    GeneReviews at GeneTests: Medical Genetics Information Resource
    http://www.genetests.org
    University of Washington, Seattle, WA - 1/1/2006
  • Developmental aspects of hepatic bile acid transport. Proceedings of the 2nd Ringberg conference on cell biology and molecular basis of liver transport 
    Projekt
    Verlag, Dortmund - 1/1/1995

Press Mentions

  • Maraxilibat Reduces Debilitating Itching in Children with Alagille Syndrome
    Maraxilibat Reduces Debilitating Itching in Children with Alagille SyndromeNovember 19th, 2020
  • Mirum Pharmaceuticals Announces Data Presented During AASLD Highlighting Durable Improvements in Pruritus and Quality of Life in Children with Alagille Syndrome Treated with Maralixibat
    Mirum Pharmaceuticals Announces Data Presented During AASLD Highlighting Durable Improvements in Pruritus and Quality of Life in Children with Alagille Syndrome Treated with MaralixibatNovember 15th, 2020
  • Mirum Pharmaceuticals Provides Third Quarter 2020 Financial Results and Business Update, and Announces Virtual Investor Day
    Mirum Pharmaceuticals Provides Third Quarter 2020 Financial Results and Business Update, and Announces Virtual Investor DayNovember 12th, 2020
  • Join now to see all

Hospital Affiliations